Manufacturers Get Their Say In Compendium With Off-Label Oncology Use
Executive Summary
Off-label oncology uses for three drugs have been added to the American Hospital Formulary Service Drug Information compendium, and three more are under review, all based on requests for review by the products' manufacturers
You may also be interested in...
CMS Opens Door To More Compendium Oversight In Draft White Paper
A draft white paper examining conflict of interest in the production of drug compendia appears to open the door for more oversight of the publications used for determining coverage of prescription drugs' off-label indications by Medicare and private insurers
CMS Opens Door To More Compendium Oversight In Draft White Paper
A draft white paper examining conflict of interest in the production of drug compendia appears to open the door for more oversight of the publications used for determining coverage of prescription drugs' off-label indications by Medicare and private insurers
AHFS opening compendia to outside submissions
The American Society of Health System Pharmacists is planning on accepting outside applications for its American Hospital Formulary Service Drug Information compendia. Updates to the compendia, which details off-label uses of approved drugs, currently is based on internal information tracking, gathering and priority assignment by AHFS staff. In early 2008, the group plans "to make an announcement about the inauguration of a formal application process that will supplement existing" compendia maintenance and updating activities...